Conference Details - Agenda
View all Conferences
This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Continuing Education Information
Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
The Next Generation of Monoclonal Antibodies in CLL and NHL
Hilton Americas-Houston
Houston, TX
September 25, 2008
Thursday, Sep 25, 2008
| 4:30 pm | Registration and Reception |
| 5:00 pm | Welcome and Introductions Presession Survey Richard R. Furman |
| 5:05 pm | New Directions With CD20 Monoclonal Antibodies in Chronic Lymphocytic Leukemia Michael Keating |
| 5:20 pm | A Patient With Active-Phase Chronic Lymphocytic Leukemia John C. Byrd |
| 5:30 pm | Evolution of Monoclonal Antibody Therapy for B-Cell Non-Hodgkin Lymphoma Richard R. Furman |
| 5:45 pm | Treatment of a Patient With Indolent Non-Hodgkin Lymphoma With a Second-Generation CD20 Monoclonal Antibody and Chemotherapy Myron Czuczman |
| 5:55 pm | Question-and-Answer Session Postsession Survey |
| 6:00 pm | Adjourn |
Educational Grants
An educational grant for this activity was provided by:
- GlaxoSmithKline